FDA Renews Reduced-Risk Authorization for Swedish Match's General Snus Products
核心洞察
The FDA has renewed the modified risk orders for eight General Snus (搜索) products from Swedish Match USA Inc., allowing them to continue being marketed with a reduced-risk claim.
These snus products are authorized to claim that using them instead of cigarettes lowers the risk of mouth cancer (搜索), heart disease (搜索), lung cancer (搜索), stroke (搜索), emphysema (搜索), and chronic bronchitis (搜索).
The renewal allows Swedish Match to continue marketing these products with the modified risk claim, a practice that has been in place since the initial authorization in 2019.
The U.S. Food and Drug Administration (FDA) has renewed the modified risk granted orders for eight General Snus (搜索) products manufactured by Swedish Match USA Inc., allowing the company to continue marketing these products with a claim of reduced risk compared to cigarettes. This decision follows a scientific review by the FDA and allows the products to be marketed with the claim that using General Snus instead of cigarettes puts users at a lower risk of several serious diseases.
The specific claim authorized by the FDA states: "Using General Snus (搜索) instead of cigarettes puts you at a lower risk of mouth cancer (搜索), heart disease (搜索), lung cancer (搜索), stroke (搜索), emphysema (搜索) and chronic bronchitis (搜索)." This renewal allows Swedish Match to continue communicating this message to consumers, a practice that has been in place since the initial authorization in 2019.
The eight General Snus (搜索) products covered by this renewal include:
- General Loose
- General Dry Mint Portion Original Mini
- General Portion Original Large
- General Classic Blend Portion White Large, 12-count
- General Mint Portion White Large
- General Nordic Mint Portion White Large, 12-count
- General Portion White Large
- General Wintergreen Portion White Large
This decision underscores the FDA's commitment to evaluating and regulating tobacco products based on scientific evidence, with the goal of providing consumers with accurate information about the relative risks of different products.
